Filing status
- Accounts due
- 11 September 2027
- Conf. stmt due
- 24 December 2026
Serenza Therapeutics Ltd
- Incorporated
- 11 December 2025 (10 months)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Saoussen Ben HalimaSeyed Ali Jazayeri Dezfuly
- Region
- Greater London
- Address
- 71 KingswayHolbornLondonWC2B 6ST
Officers 5 active
Officer details are public data from the Companies House register.
Ben Halima, Saoussen
Director · Appointed 1 May 2026
Canadian
Born February 1983 (43)
Director · Appointed 3 February 2026
American
Born May 1975 (51)
Dezfuly, Seyed Ali Jazayeri
Director · Appointed 20 January 2026
British
Born January 1976 (50)
British
Born December 1971 (54)
Badamchi-Zadeh, Alexander
Director · Appointed 11 December 2025
British
Born October 1987 (39)
Ownership 3 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 20 January 2026
Owns 25–50% of shares
Holds 25–50% of voting rights
Private Company Limited By Shares
Reg. no. 6267989
Corporate entity · Notified 31 December 2025
Owns 25–50% of shares (as a firm)
Holds 25–50% of voting rights
Holds 25–50% of voting rights (as a firm)
Right to appoint and remove directors
Right to appoint and remove directors (as a firm)
Limited Liability Partnership
Reg. no. Oc308829
Limited Liability Partnership
Reg. no. Oc437768
Former controllers (3)
31 December 2025
Ceased Seyed Ali Jazayeri Dezfuly — Owns 75–100% of shares
24 December 2025
Ceased SV Health Managers LLP — Owns 75–100% of shares (as a firm)
24 December 2025
Ceased SV Bco I GP LLP — Owns 75–100% of shares
Group structure 21 shown
Ownership group derived from the Companies House PSC register
DDF 2 FP GP LLP Holds 25–50% of voting rights
DDF 2 FP LP Has significant influence or control
DDF 2 GP LLP Holds 25–50% of voting rights
SV Bco I FP GP LLP Holds 25–50% of voting rights
SV Bco I FP LP Right to appoint and remove a person
SV Bco I GP LLP Holds 25–50% of voting rights
Serenza Therapeutics Ltd This company Owns 25–50% of shares
SV Health Managers LLP Holds 75–100% of voting rights
Dementia Discovery GP LP Has significant influence or control
Harness Therapeutics Limited Holds 75–100% of voting rights
Loqus23 Therapeutics Limited Owns 25–50% of shares
SV DDF Number 1 Limited Owns 75–100% of shares
Dementia Discovery General Partner LLP Holds 75–100% of voting rights
SV DDF Number 2 Limited Owns 75–100% of shares
SV7 (Imf) FP LP Has significant influence or control
SV7 (Imf) FP GP LLP Holds 25–50% of voting rights
SV7 (Imf) GP LLP Holds 25–50% of voting rights
Cellinta Ltd Owns 75–100% of shares
SV8 Bio FP GP LLP Holds 25–50% of voting rights
SV8 Biotech FP LP Part right to 75–100% of surplus assets
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 22 July 2026 | Other filing | |||
| 28 May 2026 | Memorandum and Articles of Association | |||
| 28 May 2026 | Resolutions | |||
| 19 May 2026 | Statement of capital following an allotment of shares | |||
| 12 May 2026 | Appointment of a director |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →